Altman J. Xanthoma disseminatum. Archives of Dermatology. 1962;86(5):582. doi:10.1001/archderm.1962.01590110018003
Deprez M, Uffer S. Clinicopathological features of eyelid skin tumors: a retrospective study of 5504 cases and review of literature. Am J Dermatopathol. 2009;31(3):256-262. doi:10.1097/DAD.0b013e3181961861
Gupta M, Sharma R, Gulati A, Gupta A. Diffuse normolipemic plane xanthoma with underlying photosensitive dermatoses. BMJ Case Reports. 2019;12(11):e230720. doi:10.1136/bcr-2019-230720
Javadifar A, Rastgoo S, Banach M, Jamialahmadi T, Johnston TP, Sahebkar A. Foam cells as therapeutic targets in atherosclerosis with a focus on the regulatory roles of non-coding RNAs. International Journal of Molecular Sciences. 2021;22(5):2529. doi:10.3390/ijms22052529
Lee CW, Lee JJ, Lee YF, et al. Clinical and molecular genetic features of cerebrotendinous xanthomatosis in Taiwan: report of a novel CYP27A1 mutation and literature review. J Clin Lipidol. 2019;13(6):954-959.e1. doi:10.1016/j.jacl.2019.10.001
Sethuraman G, Thappa DM, Karthikeyan K. Intertriginous xanthomas: A marker of homozygous familial hypercholesterolemia. Indian Pediatr. 2000;37(3):338.
Wong JC, Walsh K, Hayden D, Eichler FS. Natural history of neurological abnormalities in cerebrotendinous xanthomatosis. J Inherit Metab Dis. 2018;41(4):647-656. doi:10.1007/s10545-018-0152-9
Zak A, Zeman M, Slaby A, Vecka M. Xanthomas: Clinical and pathophysiological relations. Biomedical Papers. 2014;158(2):181-188. doi:10.5507/bp.2014.016




